Our systems are based on patented cuvette technology
Worldwide for more than 25 years
HemoCue, A Quest Diagnostics Company
The two inventors of the HemoCue system, Sven-Erik Nilsson and Jan Lilja started the work with the cuvette concept already in 1974.
Still, our systems are based on patented cuvette technology, unique reagent chemistry and analyte-specific instruments. The systems do not require mixing of reagents, dispensing, or pipetting. The instruments are factory-calibrated and all cuvettes are produced such that no adjustment for batch-to-batch variation is necessary. With a minimum of product training and instrument maintenance, this makes it possible also for staff without laboratory training to consistently perform tests yielding accurate results.
HemoCue has been on the market for more than 25 years. HemoCue is truly a pioneer in near patient testing, and the +25-year horizon we can now point to, is a powerful confirmation of this.
The first HemoCue Hemoglobin system was sold the 26th of October 1982 to the Primary Care Centre in Hässleholm, Sweden. Today we have products measuring hemoglobin, glucose in whole blood, albumin in urine and white blood cell count, and have delivered around 250 000 analyzers all around the world.
HemoCue is a company with products for different applications, with many customers and various segments. Blood banks, medical offices in primary care, public healthcare screening programs, critical care departments in hospitals (emergency rooms, neonatal and adult intensive care units, operating rooms and post-operative care), dialysis clinics, diabetes clinics and outpatient surgery centers.
For further information about our products and clinical applications,
Since the first of February 2007, HemoCue is owned by Quest Diagnostics (www.questdiagnostics.com). The HemoCue product line is sold in more than 120 countries through a highly effective organization consisting of independent distributor partners and subsidiaries.
HemoCue is a company that has developed a keen sensitivity for the needs of customers in primary health care settings and a focus on preventative health care opportunities. Given current global trends in these areas, we are convinced our products will continue to provide valuable opportunities on a world wide basis, for a long time to come.
